{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T21:08:52Z","timestamp":1778533732502,"version":"3.51.4"},"reference-count":30,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Diagnosing periprosthetic joint infection (PJI) after megaprosthetic reconstruction may be difficult due to altered inflammatory responses, extensive prior surgery, and the limited performance of conventional criteria such as the 2018 ICM score. Synovial calprotectin is a rapid neutrophil-derived biomarker that may improve diagnostic accuracy in this challenging setting. The primary aim of this study was to evaluate the diagnostic performance of synovial calprotectin in detecting periprosthetic infection in patients treated with tumor megaprostheses; secondary aims included comparison with ICM classification, assessment in infection classification-inconclusive cases, and exploratory performance in patients with low CRP. Methods: This prospective study included 20 consecutive megaprosthesis patients evaluated for suspected PJI at ATTIKON University Hospital, Athens, with a minimum follow-up of 1 year after biomarker testing. Synovial calprotectin was measured using a lateral-flow assay (positive \u2265 50 mg\/L) and compared with a predefined infection reference standard. ICM final status (0 = aseptic, 1 = inconclusive, 2 = infected) was recorded for all cases. Other synovial biomarkers (\u03b1-defensin, leukocyte esterase, synovial D-dimer) were not routinely available. The cohort had a mean age of 52.9 \u00b1 22.5 years, 70% were male, and reconstructions involved the knee (80%), hip (15%), and humerus (5%). Preoperative cultures were positive in 40%, the median systemic WBC was 7100\/\u03bcL, and the median time from last surgery to testing was 1.0 years (IQR 0.46\u20132.0). Among infected cases, the most common microorganisms were coagulase-negative staphylococci (61.5%) and Staphylococcus aureus (23.1%), with 30.8% demonstrating polymicrobial infection. Results: Thirteen of 20 patients (65%) were classified as infected. Using the \u226550 mg\/L threshold, synovial calprotectin demonstrated high apparent diagnostic accuracy in this exploratory cohort, and no false positives, yielding a sensitivity of 92.3%, specificity of 100%, PPV of 100%, NPV of 87.5%, LR+ = \u221e, and LR\u2212 = 0.08. The AUC for continuous values was 1.00. Agreement with the ICM final classification was substantial (\u03ba = 0.76), with no directional discordance (McNemar p = 1.00). Among the three ICM-inconclusive cases, calprotectin correctly reclassified two (66.7%). In patients with low CRP (&lt;10 mg\/L), a clinically difficult subgroup, calprotectin maintained strong performance (sensitivity 75%, specificity 100%, NPV 85.7%). Conclusion: Synovial calprotectin demonstrated promising diagnostic performance for PJI in megaprosthesis patients, with high sensitivity and specificity, and substantial agreement with the 2018 ICM criteria. It successfully clarified most ICM-inconclusive cases and remained reliable even in patients with low CRP. These findings support calprotectin as a valuable adjunctive biomarker in the complex diagnostic environment of megaprosthetic reconstruction and justify further validation in larger cohorts.<\/jats:p>","DOI":"10.3390\/cancers18101511","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T20:14:16Z","timestamp":1778530456000},"page":"1511","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Accuracy of Synovial Calprotectin in Megaprosthetic Reconstructions: A Prospective Cohort Study from a Tertiary Sarcoma Center"],"prefix":"10.3390","volume":"18","author":[{"given":"Panayiotis","family":"Gavriil","sequence":"first","affiliation":[{"name":"First Department of Orthopaedics, ATTIKON University General Hospital, National and Kapodistrian University of Athens, 12461 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavlos","family":"Altsitzioglou","sequence":"additional","affiliation":[{"name":"First Department of Orthopaedics, ATTIKON University General Hospital, National and Kapodistrian University of Athens, 12461 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4759-4814","authenticated-orcid":false,"given":"Ioannis","family":"Trikoupis","sequence":"additional","affiliation":[{"name":"First Department of Orthopaedics, ATTIKON University General Hospital, National and Kapodistrian University of Athens, 12461 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efthalia","family":"Maleka","sequence":"additional","affiliation":[{"name":"First Department of Orthopaedics, ATTIKON University General Hospital, National and Kapodistrian University of Athens, 12461 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9789-9002","authenticated-orcid":false,"given":"Panagiotis","family":"Briassoulis","sequence":"additional","affiliation":[{"name":"Second Department of Anesthesiology, ATTIKON University General Hospital, National and Kapodistrian University of Athens, 12461 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jendrik","family":"Hardes","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Tumororthop\u00e4die, Universit\u00e4tsklinikum Essen, 45143 Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panayiotis","family":"Papagelopoulos","sequence":"additional","affiliation":[{"name":"First Department of Orthopaedics, ATTIKON University General Hospital, National and Kapodistrian University of Athens, 12461 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6356-4346","authenticated-orcid":false,"given":"Vasileios","family":"Kontogeorgakos","sequence":"additional","affiliation":[{"name":"First Department of Orthopaedics, ATTIKON University General Hospital, National and Kapodistrian University of Athens, 12461 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2106\/00004623-200504000-00021","article-title":"Periprosthetic infection in patients treated for an orthopaedic oncological condition","volume":"87","author":"Jeys","year":"2005","journal-title":"J. Bone Jt. Surg. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1051\/sicotj\/2024008","article-title":"Risk factors for peri-megaprosthetic joint infections in tumor surgery: A systematic review","volume":"10","author":"Karampikas","year":"2024","journal-title":"SICOT J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1051\/sicotj\/2025031","article-title":"Implant survival and risk factors for failure after proximal femoral megaprosthetic reconstruction","volume":"11","author":"Roustemis","year":"2025","journal-title":"SICOT J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/CORR.0000000000000630","article-title":"Causes and Frequencies of Reoperations After Endoprosthetic Reconstructions for Extremity Tumor Surgery: A Systematic Review","volume":"477","author":"Thornley","year":"2019","journal-title":"Clin. Orthop."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e21.00003","DOI":"10.2106\/JBJS.OA.21.00003","article-title":"The Fate of Periprosthetic Joint Infection Following Megaprosthesis Reconstruction","volume":"6","author":"Sukhonthamarn","year":"2021","journal-title":"JBJS Open Access"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2106\/JBJS.22.01135","article-title":"Patient and Surgical Risk Factors for Surgical Site Infection in Lower-Extremity Oncological Endoprosthetic Reconstruction: A Secondary Analysis of the PARITY Trial Data","volume":"105","author":"Gazendam","year":"2023","journal-title":"J. Bone Jt. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Gonzalez, M.R., Pretell-Mazzini, J., and Lozano-Calderon, S.A. (2023). Risk Factors and Management of Prosthetic Joint Infections in Megaprostheses\u2014A Review of the Literature. Antibiotics, 13.","DOI":"10.3390\/antibiotics13010025"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.arth.2025.04.009","article-title":"What Is the Diagnostic Performance and Accuracy of Serum Inflammatory Biomarkers and Synovial Fluid Analysis in Megaprosthetic Periprosthetic Joint Infections?","volume":"40","author":"Gonzalez","year":"2025","journal-title":"J. Arthroplast."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.arth.2019.03.013","article-title":"Traditional Laboratory Markers Hold Low Diagnostic Utility for Immunosuppressed Patients with Periprosthetic Joint Infections","volume":"34","author":"Lazarides","year":"2019","journal-title":"J. Arthroplast."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.3928\/01477447-20230310-08","article-title":"The Fate of the Inconclusive Periprosthetic Joint Infection Workup and Reliability of Data Points","volume":"46","author":"Antonios","year":"2023","journal-title":"Orthopedics"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.arth.2018.02.078","article-title":"The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria","volume":"33","author":"Parvizi","year":"2018","journal-title":"J. Arthroplast."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3928\/01477447-20111021-24","article-title":"Infected Tumor Prostheses","volume":"34","author":"Mavrogenis","year":"2011","journal-title":"Orthopedics"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Karampikas, V., Goumenos, S., Tsantes, A.G., Trikoupis, I.G., Gavriil, P., Roustemis, A.G., Zikopoulos, A., Petrakis, V., Papadopoulos, D.V., and Ioannou, P. (2026). Microbiological Characteristics and Clinical Outcomes of Periprosthetic Infections Following Oncologic Megaprosthetic Reconstruction: A Retrospective Cohort Study. Pathogens, 15.","DOI":"10.3390\/pathogens15030306"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1007\/s00167-016-4230-y","article-title":"Accuracy of diagnostic tests for prosthetic joint infection: A systematic review","volume":"24","author":"Ahmad","year":"2016","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1051\/sicotj\/2024019","article-title":"Point of care testing for the diagnosis of periprosthetic joint infections: A review","volume":"10","author":"Altsitzioglou","year":"2024","journal-title":"SICOT J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2106\/JBJS.18.00632","article-title":"Diagnostic Accuracy of Serum, Synovial, and Tissue Testing for Chronic Periprosthetic Joint Infection After Hip and Knee Replacements: A Systematic Review","volume":"101","author":"Carli","year":"2019","journal-title":"J. Bone Jt. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/10408363.2025.2463634","article-title":"Analytical and clinical considerations of synovial fluid calprotectin in diagnosing periprosthetic joint infections","volume":"62","author":"Alkadhem","year":"2025","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1007\/s00402-024-05416-0","article-title":"Synovial calprotectin in prosthetic joint infection. A systematic review and meta-analysis of the literature","volume":"144","author":"Festa","year":"2024","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00264-022-05357-6","article-title":"Synovial fluid calprotectin in diagnosing periprosthetic joint infection: A meta-analysis","volume":"46","author":"Hantouly","year":"2022","journal-title":"Int. Orthop."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13018-021-02895-4","article-title":"Diagnostic accuracy of calprotectin in periprosthetic joint infection: A diagnostic meta-analysis","volume":"17","author":"Xing","year":"2022","journal-title":"J. Orthop. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.arth.2017.11.006","article-title":"Synovial Calprotectin: An Inexpensive Biomarker to Exclude a Chronic Prosthetic Joint Infection","volume":"33","author":"Ploegmakers","year":"2018","journal-title":"J. Arthroplast."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e012799","DOI":"10.1136\/bmjopen-2016-012799","article-title":"STARD 2015 guidelines for reporting diagnostic accuracy studies: Explanation and elaboration","volume":"6","author":"Cohen","year":"2016","journal-title":"BMJ Open"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13018-021-02746-2","article-title":"Synovial calprotectin for the diagnosis of periprosthetic joint infection: A diagnostic meta-analysis","volume":"17","author":"Peng","year":"2022","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.arth.2021.12.040","article-title":"Synovial Biomarkers to Detect Chronic Periprosthetic Joint Infection: A Pilot Study to Compare Calprotectin Rapid Test, Calprotectin ELISA Immunoassay and Leukocyte Esterase Test","volume":"37","author":"Grassi","year":"2022","journal-title":"J. Arthroplast."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.21873\/invivo.13258","article-title":"Synovial Calprotectin for Diagnosing Periprosthetic Joint Infection in Loose Hip and Knee Arthroplasties: A Prospective Cohort Study","volume":"37","author":"Lazic","year":"2023","journal-title":"In Vivo"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1302\/0301-620X.104B3.BJJ-2021-1320.R1","article-title":"Synovial fluid calprotectin performs better than synovial fluid polymerase chain reaction and interleukin-6 in the diagnosis of periprosthetic joint infection: A systematic review and meta-analysis","volume":"104-B","author":"Cheok","year":"2022","journal-title":"Bone Jt. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1111\/os.13500","article-title":"Reliable Diagnostic Tests and Thresholds for Preoperative Diagnosis of Non-Inflammatory Arthritis Periprosthetic Joint Infection: A Meta-analysis and Systematic Review","volume":"14","author":"Tang","year":"2022","journal-title":"Orthop. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.arth.2019.08.052","article-title":"Synovial Fluid Calprotectin for the Preoperative Diagnosis of Chronic Periprosthetic Joint Infection","volume":"35","author":"Salari","year":"2020","journal-title":"J. Arthroplast."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1016\/j.arth.2023.06.017","article-title":"Synovial Fluid Biomarkers for the Diagnosis of Periprosthetic Joint Infection\u2014A Systematic Review and Meta-Analysis of Their Diagnostic Accuracy According to Different Definitions","volume":"38","author":"Vale","year":"2023","journal-title":"J. Arthroplast."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3899\/jrheum.140628","article-title":"Calprotectin as a Biomarker for Rheumatoid Arthritis: A Systematic Review","volume":"42","author":"Abildtrup","year":"2015","journal-title":"J. Rheumatol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/10\/1511\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T20:22:53Z","timestamp":1778530973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/10\/1511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["cancers18101511"],"URL":"https:\/\/doi.org\/10.3390\/cancers18101511","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]}}}